Unknown PHASE1 INTERVENTIONAL 1-arm NCT03236064

Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury

Sponsor: Neuraptive Therapeutics Inc.

Conditions Injury of Other Nerves at Wrist and Hand Level of Unspecified Arm, Initial Encounter

Updated 8 times since 2017 Last updated: Jan 22, 2021 Started: May 31, 2016 Primary completion: May 31, 2024 Completion: May 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Injury of Other Nerves at Wrist and Hand Level of Unspecified Arm, Initial Encounter and is currently ongoing. Neuraptive Therapeutics Inc. leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jun 2024 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Feb 2021 — Jun 2024 [monthly]

Recruiting PHASE1
Jan 2021 — Feb 2021 [monthly]

Recruiting PHASE1

▶ Show 3 earlier versions

Nov 2019 — Jan 2021 [monthly]

Recruiting PHASE1
Jun 2018 — Nov 2019 [monthly]

Recruiting PHASE1
Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE1

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neuraptive Therapeutics Inc.
WellSpan Health

Data source: WellSpan Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• York, United States